CTRI/2024/08/072216尚未招募2 期
An Open Label Randomised Study To Compare The Effect Of Marichadi Anjana And Saugata Anjana In Dwitiya Patalagata Timira Vis-A-Vis Presbyopia - nil
Dr Kasturi Aloni0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subjects of either gender between the age group of 40-55 years presenting with Lakshanas of Dwitiya Patalagata Timira and clinical features of Presbyopia
- •Near visual acuity in between N8 to N36 in near vision chart without aid
- •Optical correction ranging from +0.5 D to + 3.0 D
- •Subjects fit for Anjana
排除标准
- •Subjects suffering from systemic disorders that may interfere with course of study
- •Subjects with known history of any other known ocular pathology like cataract, corneal opacity, iridocylclitis, chorio retinitis, ocular trauma or ocular surgeries
研究者
相似试验
尚未招募
2 期
A Clinical Study To Compare The Effect Of Kanadya Churna (Medicated powder)Pratisarana With And Without Irimedadi Taila (Medicated oil) Gandusha In Sheetada (Bleeding Gums)CTRI/2024/08/072142Dr Roshini R
尚未招募
2 期
Kushtadi churna and pippalyadi churna pratisarana in tundikeri vis-a-vis chronic tonsillitisCTRI/2024/05/067358Dr MD Shahid Musaib
进行中（未招募）
不适用
A Randomized, Open-Label, Study to Compare the Efficacy and Safety of AT1001 and Enzyme Replacement Therapy (ERT) in Patients With Fabry Disease and AT1001-Responsive GLA Mutations, Who Were Previously Treated With ERT - AT1001-012MedDRA version: 14.1Level: PTClassification code 10016016Term: Fabry's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disordersFabry diseaseEUCTR2010-022636-37-ITAMICUS THERAPEUTICS, INC50
进行中（未招募）
1 期
A Study of Xenical (Orlistat) in Overweight and Obese AdolescentsEUCTR2016-001661-91-Outside-EU/EEAF. Hoffmann-La Roche AG80
尚未招募
4 期
Role of Melbild Solution in the treatment of VitiligoCTRI/2017/06/008845Alkem Laboratories Limited120